A recent study by Bellet et al., 2021 demonstrated that one of the core circadian clock proteins, period 1 (PER1), and the tumor suppressor protein p53 negatively cross-regulate each other’s activity and expression to modulate the sensitivity of tumor cells to chemotherapy. The gene discussed is PER1; the disease is neoplasm.